Combined Estrogen-Progestogen Contraceptives (IARC Monograph Vol 100A)

International Agency for Research on Cancer

Combined Estrogen-Progestogen Contraceptives (IARC Monograph Vol 100A)

International Agency for Research on Cancer, 2012

Source

Abstract

No abstract available for this article.

Topics

Contraception/Comparison > Oral Contraceptives > Carcinogenicity Classification General OB/GYN > Cancer Risk > Hormonal Contraceptive-Associated Cancers

IARC monograph combined estrogen progestogen contraceptives carcinogenicity, oral contraceptive cancer risk IARC classification group 1, combined hormonal contraceptive carcinogen classification evidence, estrogen progestogen contraceptive breast cervical cancer IARC, IARC volume 100A hormonal contraceptives cancer evaluation, oral contraceptive endometrial ovarian cancer protective effect, combined oral contraceptive hepatocellular carcinoma IARC, hormonal contraception cancer epidemiology international agency research, OCP carcinogenicity evidence review IARC monograph, estrogen progestogen combination cancer risk benefit assessment

Cite this article

International Agency for Research on Cancer (2012). *Combined Estrogen-Progestogen Contraceptives (IARC Monograph Vol 100A)*.